BRIEF published on 05/17/2024 at 15:05, 1 year 9 months ago Protenus reconnu pour l'excellence en milieu de travail en 2024 Protenus Analyse Des Soins De Santé La Satisfaction Des Employés Excellence Du Lieu De Travail Certification Great Place To Work
BRIEF published on 05/17/2024 at 15:05, 1 year 9 months ago Protenus Recognized for Workplace Excellence in 2024 Employee Satisfaction Protenus Healthcare Analytics Workplace Excellence Great Place To Work Certification
PRESS RELEASE published on 05/17/2024 at 15:00, 1 year 9 months ago Protenus Earns Esteemed Workplace Honors for 2024 Protenus recognized as one of the 2024 Modern Healthcare Best Places to Work in Healthcare and a Great Place to Work® for the fifth year, highlighting commitment to employee well-being and workplace culture Healthcare Compliance Work-life Balance Protenus Great Place To Work® Employee-centric Culture
BRIEF published on 04/04/2024 at 16:05, 1 year 10 months ago Protenus remporte un accord de solutions logicielles de détournement de médicaments avec Premier, Inc. Protenus Conformité Des Soins De Santé Premier Inc. Prévention Du Détournement De Drogues Technologie De Surveillance
BRIEF published on 04/04/2024 at 16:05, 1 year 10 months ago Protenus Awarded Drug Diversion Software Solutions Agreement With Premier, Inc. Healthcare Compliance Protenus Premier Inc. Drug Diversion Prevention Surveillance Technology
PRESS RELEASE published on 04/04/2024 at 16:00, 1 year 10 months ago Protenus Awarded Drug Diversion Software Solutions Agreement With Premier, Inc. Protenus awarded national group purchasing agreement with Premier, Inc. for Drug Diversion Software Solutions, offering Premier members special pricing and terms for Protenus solution Healthcare Protenus Premier Inc. Drug Diversion Supplier Contract
BRIEF published on 04/02/2024 at 16:05, 1 year 10 months ago Protenus Secures Two Innovative Patents for Enhancing Healthcare Compliance Healthcare Compliance Protenus Patient Privacy Monitoring Technology Innovation U.S. Patents
BRIEF published on 04/02/2024 at 16:05, 1 year 10 months ago Protenus obtient deux brevets innovants pour améliorer la conformité des soins de santé Innovation Technologique Protenus Conformité Des Soins De Santé Surveillance De La Confidentialité Des Patients Brevets Américains
PRESS RELEASE published on 04/02/2024 at 16:00, 1 year 10 months ago Protenus Granted Two New Patents for Healthcare Compliance Protenus expands patient privacy monitoring technology with new patents to help hospitals identify record breaches. CEO emphasizes AI-driven solutions for protecting patient data Protenus Healthcare Compliance Analytics Patient Privacy Monitoring New Patents Data Breach
BRIEF published on 03/26/2024 at 16:05, 1 year 10 months ago Protenus Granted Sixth Patent for Drug Diversion Surveillance Technology Artificial Intelligence Healthcare Compliance Protenus Drug Diversion Surveillance Patent Grant
Published on 02/20/2026 at 18:30, 16 minutes ago Sparta Updates Delay in Filing Annual Financial Statements
Published on 02/20/2026 at 15:45, 3 hours 1 minute ago Revolve Announces Closing of Initial US$10 Million Advance on Strategic Financing With Callaway
Published on 02/20/2026 at 14:30, 4 hours 16 minutes ago Norse Gold Announces Application for Reactivation to TSX-V, Private Placement Financing and Stock Options Grant
Published on 02/20/2026 at 14:08, 4 hours 38 minutes ago Datavault AI Announces Anticipated Launch of Josh Gibson Stablecoin and Josh Gibson NIL Strategies for Its Forthcoming NIL Exchange
Published on 02/20/2026 at 14:00, 4 hours 46 minutes ago Nextech3D.ai's Eventdex Platform Powers AI Matchmaking for the SBA's CT Business Matchmaker Event Featuring Government Agencies and Major Prime Contractors
Published on 02/20/2026 at 18:36, 10 minutes ago EQS-Adhoc: innoscripta SE: Management Board Proposes Dividend of EUR 4.00 per Share
Published on 02/20/2026 at 18:31, 15 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 02/20/2026 at 18:00, 46 minutes ago Leclanché conclut un accord de financement d’un montant de CHF 16,7 millions pour soutenir ses opérations à court terme
Published on 02/20/2026 at 18:00, 46 minutes ago Leclanché Secures Financing Arrangement in the amount of CHF 16.7 million to Support Near-Term Operations
Published on 02/20/2026 at 09:28, 9 hours 18 minutes ago Déclaration du nombre d'actions composant le capital social et du nombre total de droits de vote au 31 janvier 2026
Published on 02/20/2026 at 09:28, 9 hours 18 minutes ago Statement about the number of shares composing the share capital and the number of voting rights as of January 31, 2026
